# A single extinction-based treatment with N-Acetylcysteine produces long-term reduction in cocaine relapse

**Authors:** Shihao Huang, Zhihao Song, Cuijie Shi, Dan Tao, Jing Wen, Yisi Chen, Yixiao Luo

PMC · DOI: 10.1038/s41398-026-03954-2 · Translational Psychiatry · 2026-03-19

## TL;DR

N-Acetylcysteine (NAC) combined with extinction training reduces cocaine relapse in rats, with effects lasting over a month.

## Contribution

A single NAC treatment during extinction training produces long-term anti-relapse effects via mGlu2/3 receptors.

## Key findings

- NAC reduced cocaine-seeking behavior on the first day of extinction training.
- NAC's anti-relapse effects lasted at least 28 days and were blocked by an mGlu2/3 antagonist.
- NAC also reduced context-induced reinstatement of cocaine-seeking behavior.

## Abstract

Cocaine addiction is characterized by high relapse rates associated with glutamate dysregulation, presenting significant challenges for long-term treatment. N-acetylcysteine (NAC) has shown promise in preventing drug relapse by normalizing glutamate function, potentially mediated by glutamate 2/3 (mGlu2/3) receptor activation. This study investigated the therapeutic potential of NAC in reducing cocaine-seeking behavior using the self-administration model. After establishing stable cocaine self-administration and a 7-day abstinence period, rats received a single dose of NAC (100 mg/kg, i.p.) 30 min before the first extinction training session. NAC significantly reduced cocaine-seeking behavior on the first day of extinction but not in subsequent extinction sessions. Following extinction, tests for cue-induced reinstatement and spontaneous recovery were conducted. Results showed that NAC administration on the first day of extinction effectively reduced cocaine-seeking during the reinstatement test, with effects lasting at least 28 days. The mGlu2/3 antagonist LY341495 (1 mg/kg) fully blocked this enduring suppression of reinstatement without altering the immediate decrease in drug-seeking observed on the first day of extinction. Additionally, NAC administration on the initial extinction day also reduced context-induced reinstatement of cocaine-seeking behavior. These results indicate that NAC exerts its anti-relapse effects via mGlu2/3 receptors. A single NAC treatment combined with extinction training can produce lasting suppression of relapse, highlighting its therapeutic promise for addiction treatment.

## Linked entities

- **Chemicals:** N-acetylcysteine (PubChem CID 12035), LY341495 (PubChem CID 9819927)
- **Diseases:** cocaine addiction (MONDO:0005186)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Slc1a2 (solute carrier family 1 member 2) [NCBI Gene 29482] {aka Eaat2, Glt, Glt-1}, Glul (glutamate-ammonia ligase) [NCBI Gene 24957] {aka Glns}, Grm5 (glutamate metabotropic receptor 5) [NCBI Gene 24418] {aka mGluR5, mGlur5}, Slc1a3 (solute carrier family 1 member 3) [NCBI Gene 29483] {aka EAAT1, GLAST, GLAST-1, GluT-1}, Gria1 (glutamate ionotropic receptor AMPA type subunit 1) [NCBI Gene 50592] {aka GluA1, gluR-A}
- **Diseases:** glutamate (MESH:C537425), inflammatory (MESH:D007249), overdose (MESH:D062787), CUD (MESH:D019970), addiction (MESH:D019966), locomotor impairments (MESH:D001523), paranoia (MESH:D010259), glutamatergic dysregulation (MESH:D021081), infection (MESH:D007239), craving (MESH:C564883)
- **Chemicals:** dopamine (MESH:D004298), water (MESH:D014867), saline (MESH:D012965), N-Acetylcysteine (MESH:D000111), LY341495 (MESH:C114624), cystine (MESH:D003553), isoflurane (MESH:D007530), penicillin (MESH:D010406), glutamate (MESH:D018698), Methamphetamine (MESH:D008694), glutathione (MESH:D005978), nicotine (MESH:D009538), alcohol (MESH:D000438), Cocaine (MESH:D003042), HC (MESH:D006854), heroin (MESH:D003932), VEH (-), ethanol (MESH:D000431)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039927/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039927/full.md

---
Source: https://tomesphere.com/paper/PMC13039927